5-HT1A and 5-HT2A receptor control of a panic-like defensive response in the rat dorsomedial hypothalamic nucleus

Journal of Psychopharmacology

Volumn 27, Issue 12, 2013, Pages 1116-1123

  De Bortoli, Valquíria Camin ^a   Yamashita, Paula Shimene De Melo ^b   Zangrossi, Hélio ^b  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

antidepressants; dorsomedial hypothalamus; escape; imipramine and fluoxetine; Panic; serotonin

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 6 CHLORO 2 (1 PIPERAZINYL)PYRAZINE; BENZATHINE PENICILLIN; FLUNIXIN; FLUOXETINE; IMIPRAMINE; KETANSERIN; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; STREPTOMYCIN; SEROTONIN AGONIST; SEROTONIN ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHRONIC DRUG ADMINISTRATION; DEFENSIVE BEHAVIOR; DORSOMEDIAL HYPOTHALAMIC NUCLEUS; DRUG EFFECT; DRUG MECHANISM; ELECTROSTIMULATION; ESCAPE BEHAVIOR; INFECTION; MALE; MICROINJECTION; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; PANIC; PERIAQUEDUCTAL GRAY MATTER; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SYSTEMIC THERAPY; ANIMAL; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; WISTAR RAT;

ANIMALS; DORSOMEDIAL HYPOTHALAMIC NUCLEUS; ELECTRIC STIMULATION; ESCAPE REACTION; FLUOXETINE; IMIPRAMINE; MALE; PANIC; PERIAQUEDUCTAL GRAY; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN; SEROTONIN ANTAGONISTS; SEROTONIN RECEPTOR AGONISTS;

EID: 84887840150     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881113492900     Document Type: Article

References (62)

1. Aghajanian GK Psychopharmacology: The fourth generation of progress. Bloom FR Kupfer DJ, ed. New York: Raven ; 1995: 1451-1459.
2. Andrisano C, Chiesa A, Serretti A. Newer antidepressants and panic disorder: A meta-analysis. Int Clin Psychopharmacol. 2013 ; 28: 33-45
3. Audi EA, Graeff FG. Benzodiazepine receptors in the periaqueductal grey mediate anti-aversive drug action. Eur J Pharmacol. 1984 ; 103: 279-285
4. Beck SG, Birnstiel S, Choi KC, et al. Fluoxetine selectively alters 5-hydroxytryptamine1A and gamma-aminobutyric acid B receptor-mediated hyperpolarization in area CA1, but not area CA3, hippocampal pyramidal cells. J Pharmacol Exp Ther. 1997 ; 281: 115-122
5. Blier P, de Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol Sci. 1994 ; 15: 220-226
6. Brandão ML, Borelli KG, Nobre MJ, et al. Gabaergic regulation of the neural organization of fear in the midbrain tectum. Neurosci Biobehav Rev. 2005 ; 29: 1299-1311
7. Brandão ML, Lopez-Garcia JA, Graeff FG, et al. Electrophysiological evidence for excitatory 5-HT2 and depressant 5-HT1A receptors on neurones of the rat midbrain tectum. Brain Res. 1991 ; 556: 259-266
8. Castro M, Diaz A, del Olmo E, et al. Chronic fluoxetine induces opposite changes in G protein coupling at pre and postsynaptic 5-HT1A receptors in rat brain. Neuropharmacology. 2003 ; 44: 93-101
9. Clemett DA, Punhani T, Duxon MS, et al. Immunohistochemical localisation of the 5-HT2C receptor protein in the rat CNS. Neuropharmacology. 2000 ; 39: 123-132
10. Commons KG, Connolley KR, Valentino RJ. A neurochemically distinct dorsal raphe-limbic circuit with a potential role in affective disorders. Neuropsychopharmacology. 2003 ; 28: 206-215
11. Connor KM, Davidson JRT. Generalized anxiety disorder: Neurobiological and pharmacotherapeutic perspectives. Biol Psychiatry. 1998 ; 44: 1286-1294
12. da Silva ES, Poltronieri SC, Nascimento JO, et al. Facilitation of 5-HT(2A/2C)-mediated neurotransmission in the ventromedial hypothalamic nucleus decreases anxiety in the elevated T-maze. Behav Brain Res. 2011 ; 216: 692-698
13. Deakin JFW, Graeff FG. 5-HT and mechanisms of defense. J Psychopharmacol. 1991 ; 5: 305-315
14. de Bortoli VC, Nogueira RL, Zangrossi H. Effects of fluoxetine and buspirone on the panicolytic-like response induced by the activation of 5-HT1A and 5-HT2A receptors in the rat dorsal periaqueductal gray. Psychopharmacology (Berl). 2006 ; 183: 422-428
15. de Bortoli VC, Nogueira RL, Zangrossi H. Alprazolam potentiates the antiaversive effect induced by the activation of 5-HT(1A) and 5-HT (2A) receptors in the rat dorsal periaqueductal gray. Psychopharmacology (Berl). 2008 ; 198: 341-349
16. den Boer JA, Slaap BR. Review of current treatment in panic disorder. Int Clin Psychopharmacol. 1998 ; 13: S25 - S30
17. de Oliveira Sergio T, de Bortoli VC, Zangrossi H. Serotonin-2A receptor regulation of panic-like behavior in the rat dorsal periaqueductal gray matter: The role of GABA. Psychopharmacology (Berl). 2011 ; 218: 725-732
18. de Paula Soares V, Zangrossi H. Involvement of 5-HT1A and 5-HT2 receptors of the dorsal periaqueductal gray in the regulation of the defensive behaviors generated by the elevated T-maze. Brain Res Bull. 2004 ; 64: 181-188
19. de Paula Soares V, Campos AC, Bortoli VC, et al. Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors. Behav Brain Res. 2010 ; 213: 225-229
20. Duan YF, Winters R, McCabe PM, et al. Behavioral characteristics of defense and vigilance reactions elicited by electrical stimulation of the hypothalamus in rabbits. Behav Brain Res. 1996 ; 81: 33-41
21. Fernandez de, Molina A, Hunsperger RW. Central representation of affective reactions in forebrain and brain stem: Electrical stimulation of amygdala, stria terminalis, and adjacent structures. J Physiol. 1959 ; 145: 251-265
22. Fernandez de, Molina A, Hunsperger RW. Organization of the subcortical system governing defence and flight reactions in the cat. J Physiol. 1962 ; 160: 200-213
23. Freitas RL, Uribe-Mariño A, Castiblanco-Urbina MA, et al. GABA(A) receptor blockade in dorsomedial and ventromedial nuclei of the hypothalamus evokes panic-like elaborated defensive behaviour followed by innate fear-induced antinociception. Brain Res. 2009 ; 1305: 118-131
24. Graeff FG, Zangrossi H Textbook of biological psychiatry. D'Haenen H den Boer JA Westenberg H, ed. London: Wiley ; 2002: 879-893.
25. Graeff FG, Zangrossi H. The dual role of serotonin in defense and the mode of action of antidepressants on generalized anxiety and panic disorders. Cent Nerv Syst Agents Med Chem. 2010 ; 10: 207-217
26. Griffiths JL, Lovick TA. Co-localization of 5-HT 2A -receptor- and GABA-immunoreactivity in neurones in the periaqueductal grey matter of the rat. Neurosci Lett. 2002 ; 326: 151-154
27. Hale MW, Shekhar A, Lowry CA. Stress-related serotonergic systems: Implications for symptomatology of anxiety and affective disorders. Cell Mol Neurobiol. 2012 ; 32: 695-708
28. Hess WR, Brugger M. Das subkortikale zentrum der affectiven adwehrreaktion. Helv Physiol Pharmacol Acta. 1943 ; 1: 33-52
29. Hoyer D, Hannon JP, Martin GR. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav. 2002 ; 71: 533-554
30. Jacob CA, Cabral AH, Almeida LP, et al. Chronic imipramine enhances 5-HT(1A) and 5-HT(2) receptors-mediated inhibition of panic-like behavior in the rat dorsal periaqueductal gray. Pharmacol Biochem Behav. 2002 ; 72: 761-766
31. Jenck F, Moreau JL, Berendsen HH, et al. Antiaversive effects of 5HT2C receptor agonists and fluoxetine in a model of panic-like anxiety in rats. Eur Neuropsychopharmacol. 1998 ; 8: 161-168
32. Jenck F, Moreau JL, Karli P. Modulation by morphine of aversive-like behavior induced by GABAergic blockade in periaqueductal gray or medial hypothalamus. Pharmacol Biochem Behav. 1988 ; 31: 193-200
33. Johnson PL, Shekhar A. An animal model of panic vulnerability with chronic disinhibition of the dorsomedial/perifornical hypothalamus. Physiol Behav. 2012 ; 107: 686-698
34. Knight AR, Misra A, Quirk K, et al. Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors. Naunyn Schmiedebergs Arch Pharmacol. 2004 ; 370: 114-123
35. Koen N, Stein DJ. Pharmacotherapy of anxiety disorders: A critical review. Dialogues Clin Neurosci. 2011 ; 13: 423-437
36. Leroux AG, Myers RD. Action of serotonin microinjected into hypothalamic sites at which electrical stimulation produced aversive responses in the rat. Physiol Behav. 1975 ; 14: 501-505
37. Li Q, Battaglia G, van de, Kar LD. Autoradiographic evidence for differential G-protein coupling of 5-HT1A receptors in rat brain: lack of effect of repeated injections of fluoxetine. Brain Res. 1997b ; 769: 141-151
38. Li Q, Brownfield MS, Battaglia G, et al. Long-term treatment with the antidepressants fluoxetine and desipramine potentiates endocrine responses to the serotonin agonists 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212) and (+-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane HCl (DOI). J Pharmacol Exp Ther. 1993a ; 266: 836-844
39. Li Q, Brownfield MS, Levy AD, et al. Attenuation of hormone responses to the 5-HT1A agonist ipsapirone by long-term treatment with fluoxetine, but not desipramine, in male rats. Biol Psychiatry. 1994 ; 36: 300-308
40. Li Q, Levy AD, Cabrera TM, et al. Long-term fluoxetine, but not desipramine, inhibits the ACTH and oxytocin responses to the 5-HT1A agonist, 8-OH-DPAT, in male rats. Brain Res. 1993b ; 630: 148-156
41. Li Q, Muma NA, Battaglia G, et al. Fluoxetine gradually increases [125I]DOI-labelled 5-HT2A/2C receptors in the hypothalamus without changing the levels of Gq- and G11-proteins. Brain Res. 1997a ; 775: 225-228
42. Li Q, Muma NA and, van de, Kar LD. Chronic fluoxetine induces a gradual desensitization of 5-HT1A receptors: Reductions in hypothalamic and midbrain Gi and G(o) proteins and in neuroendocrine responses to a 5-HT1A agonist. J Pharmacol Exp Ther. 1996 ; 279: 1035-1042
43. Markgraf CG, Winters RW, Liskowsky DR, et al. Hypothalamic, midbrain and bulbar areas involved in the defense reaction in rabbits. Physiol Behav. 1991 ; 49: 493-500
44. Maron E, Nutt D, Shlik J. Neuroimaging of serotonin system in anxiety disorders. Curr Pharm Des. 2012 ; 18: 5699-5708
45. Marseillan RF. A solid state sine-wave stimulator. Physiol Behav. 1977 ; 19: 339-340
46. Millan MJ. Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: Focus on novel therapeutic strategies. Therapie. 2005 ; 60: 441-460
47. Mongeau R, Marsden CA. Effect of imipramine treatments on the 5-HT1A-receptor-mediated inhibition of panic-like behaviours in rats. Psychopharmacology. 1997 ; 131: 321-328
48. Nierenberg AA, Farabaugh AH, Alpert JE, et al. Timing of onset of antidepressant response with fluoxetine treatment. Am J Psychiatry. 2000 ; 157: 1423-1428
49. Nogueira RL, Graeff FG. Role of 5-HT receptor subtypes in the modulation of dorsal periaqueductal gray generated aversion. Pharmacol Biochem Behav. 1995 ; 52: 1-6
50. Paxinos G, Watson C The rat brain in stereotaxic coordinates. 2007 ) The rat brain in stereotaxic coordinates, 6th ed.London: Academic Press. London: Academic Press ; 2007:
51. Phelix CF, Adai DM, Cantu C, et al. Immunohistochemical demonstration of serotonin-containing axons in the hypothalamus of the white-footed mouse. Peromyscus leucopus. Brain Res. 1998 ; 808: 197-219
52. Schmitt P, Sandner G, Colpaert FC, et al. Effects of dorsal raphe stimulation on escape induced by medial hypothalamic or central gray stimulation. Behav Brain Res. 1983 ; 8: 289-307
53. Schneier FR, Liebowitz MR, Davies SO, et al. Fluoxetine in panic disorder. J Clin Psychopharmacol. 1990 ; 10: 119-121
54. Schütz MT, de Aguiar JC, Graeff FG. Anti-aversive role of serotonin in the dorsal periaqueductal grey matter. Psychopharmacology (Berl). 1985 ; 85: 340-345
55. Shekhar A. Effects of treatment with imipramine and clonazepam on an animal model of panic disorder. Biol Psychiatry. 1994 ; 36: 748-758
56. Shen C, Li H, Meller E. Repeated treatment with antidepressants differentially alters 5-HT1A agonist-stimulated [35S]GTP gamma S binding in rat brain regions. Neuropharmacology. 2002 ; 42: 1031-1038
57. Silveira MC, Sandner G, Di Scala G, et al. c-fos immunoreactivity in the brain following electrical or chemical stimulation of the medial hypothalamus of freely moving rats. Brain Res. 1995 ; 674: 265-274
58. Wilent WB, Oh MY, Buetefisch CM, et al. Induction of panic attack by stimulation of the ventromedial hypothalamus. J Neurosurg. 2010 ; 12: 1295-1298
59. Yamashita PS, de Bortoli VC, Zangrossi H. 5-HT2C receptor regulation of defensive responses in the rat dorsal periaqueductal gray. Neuropharmacology. 2011 ; 60: 216-222
60. Zanoveli JM, Nogueira RL, Zangrossi H. Chronic imipramine treatment sensitizes 5-HT1A and 5-HT2A receptors in the dorsal periaqueductal gray matter: Evidence from the elevated T-maze test of anxiety. Behav Pharmacol. 2005 ; 16: 543-552
61. Zanoveli JM, Nogueira RL, Zangrossi H. Enhanced reactivity of 5-HT1A receptors in the rat dorsal periaqueductal gray matter after chronic treatment with fluoxetine and sertraline: evidence from the elevated T-maze. Neuropharmacology. 2007 ; 52: 1188-1195
62. Zanoveli JM, Pobbe RL, de Bortoli VC, et al. Facilitation of 5-HT1A-mediated neurotransmission in dorsal periaqueductal gray matter accounts for the panicolytic-like effect of chronic fluoxetine. Int J Neuropsychopharmacol. 2010 ; 13: 1079-1088